Lecture

Spinal Muscular Atrophy: Genetic Insights and Therapeutic Strategies

Description

This lecture covers Spinal Muscular Atrophy (SMA), an autosomal recessive disease caused by mutations in the SMN1 gene, leading to muscle weakness, atrophy, and neurodegeneration. Different disease classes are discussed based on severity, age of onset, and life expectancy. The role of the SMN2 gene in SMA pathogenesis is explained, focusing on exon splicing and protein levels. Gene therapy strategies for SMA are explored, highlighting the importance of SMN2 copy numbers and potential clinical benefits.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.